Global Economic Impact and 2020 Outlook

Under Armour (UAA): Forensic & Fundamental Review

Published August 04, 2020

Model Portfolio Solutions: Top Ten

Published July 31, 2020

Restaurants Industry: Covid-19 Impact & Road to Recovery

Published July 06, 2020

CFRA Model Portfolios: Driven by Proprietary Qualitative & Quantitative Ranking Systems

Published July 01, 2020

Model Portfolio Solutions: Intrinsic Value (IV)

Published June 25, 2020

LATEST RESEARCH

Hospitality: Covid-19 Headwinds for the Hotel Chains on the Tortuous Road to Recovery 

Published July 27, 2020

We see the global hospitality reeling from the Covid-19 disruption, with the key industry metrics recently coming off all-time nadir levels. Consequently, the near-term visibility on travel spending remains clouded, with air and road travel recently showing mixed signals.

Medical Services: Potential Jump in Diabetes Rate – a Positive for Fundamentals of Dialysis Providers

Published July 27, 2020

There is a high correlation between U.S. recessions and increases in diabetes prevalence. Given record levels of U.S. unemployment, we anticipate the 2020 recession will have a stronger adverse impact on kidney health than the past three recessions.

Great Britain Energy Retail: What Doesn't Kill You, Makes You Stronger 

Published July 27, 2020

We expect U.K. energy retailers to be hit by weaker energy demand and rising bad debt following the Covid-19 outbreak. This will likely accelerate the pace of industry consolidation, as small suppliers with unsustainable business practices could struggle to stay afloat.

Industrials: Insight from Trends in Non-Residential Construction Spending 

Published July 20, 2020

The Covid-19 pandemic will likely have a significant impact on global non-residential construction spending in 2020 and 2021, causing uncertainty for large-cap machinery companies.

Automobiles: Covid-19 Trends Will Cause Some to Accelerate, Others to Slam the Brakes

Published July 20, 2020

The U.S. and global auto markets experienced an unprecedented level of disruption in the first half of 2020 due to Covid-19, which dramatically impacted sales, production, and inventory levels. From the carnage, new trends have emerged which we believe will shape industry fundamentals in the coming months and years. 

European Pharmaceuticals: Late-Stage Pipeline Will Minimize Impact from Covid-19 Disruptions 

Published July 20, 2020

With many health care resources being constrained by the Covid-19 pandemic, we anticipate clinical trials and approval process for non-Covid-19 medicines to be disrupted. The disruption may cause delays in the approval timeline, and hence, impede revenue for pharmaceutical companies.

Airlines: A Winnerless Price War is Likely Underway 

Published July 10, 2020

Expectations for the airline industry appear to be that a quicker recovery for domestic leisure travel will allow smaller, low-cost leisure (LCL) focused airlines to outperform major airlines. We think this view is mistaken, as major airlines are increasing capacity on leisure routes, taking market share from LCLs.

Moderna: Can its Vaccine Live Up to the Hype? 

Published July 09, 2020

mRNA-based vaccines, which have never before been approved by the FDA, may have their breakout moment with Covid-19. Clinical studies and scientific research suggest that mRNA therapies could alter the R&D landscape of the biopharmaceutical industry.

CFRA WEBINARS 

Register for CFRA's upcoming webinars to keep you informed on the latest market and sector insights.

• 8/12 - Disruptive Technologies & Cloud Computing Opportunities Accelerate
• 8/26 - Health Care: Covid-19 Therapies and Investing in the Medical Landscape
• 9/9 - Invest in American Infrastructure: Opportunities, Risks, & Politics
• 9/23 - Real Estate Road to Recovery from the Abyss

8/19 Working from Home as a Long-Term Investment Theme
Join CFRA’s Head of ETF & Mutual Fund Research Todd Rosenbluth and Direxion’s Managing Director, Product, David Mazza, for a half-hour webinar as they explore long-term investment opportunities in cloud computing, cybersecurity, online project and document management and remote communication.

 

8/20 Active Equity ETFs: Can ETF Investors Still Get the Benefits of Stock Selection
CFRA Head of ETF & Mutual Fund Research Todd Rosenbluth moderates a panel of fund experts from Fidelity Investments, Davis Advisors, and Clearbridge Investments as they discuss what active equity ETFs have that Mutual Funds don't, and if investors still get the potential benefits of stock selection.